Tag: genomics
-
BASF Licensing Precise Crispr Editing from Broad Institute
The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT.
-
NVIDIA, Scripps Partner on Medical Deep Learning Applications
A high-performance computer chip maker and life science research center are collaborating on extending deep learning, a form of artificial intelligence, into more areas of medical science and practice.
-
Genome Editing, Informatics Lead to New Antibiotic
Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics.
-
Trials Evaluating Blood Tests to Guide Cancer Treatment
Researchers in Australia are conducting clinical trials of blood tests among cancer patients to help determine the course of their treatment, including the need for chemotherapy.
-
Infectious Disease Sequencing Service, Training Launched
A cloud-based open-source genomic sequencing program is underway to identify the source and nature of infectious diseases anywhere in the world.
-
Prenatal Genome Edits Prevent Inherited Liver Disorder
Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder.
-
Biotech in $3.7B Licensing Deal for Hepatitis-B
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals.
-
DNA Home Testing — Is It Worth It?
While so many of us are able to send away for one of those home testing kits to find out our ancestry, not to mention if we have a predilection towards certain diseases, are these kits valid at all?
-
Mayo Clinic, Helix Partner on Genomic Analysis
Mayo Clinic and the company Helix Opco are providing a genomic analysis service for Mayo Clinic patients seeking more detailed insights into their genetic make-up and health outlook.
-
Genome Editing Offers Marketable Wild Tomato
The groundcherry, a wild tomato plant that its devotees say has a delicious and unusual flavor, could be grown on farms for sale to consumers thanks to a genome editing project at two New York research institutes.